New Hope for the Treatment of Severe Skin Injury: Genetically Engineered Porcine Skin Xenotransplantation
Xenotransplantation · 2025
DOI: 10.1111/xen.70057 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Xenotransplantation, 2025. Verfasst von Dan Wu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Huashan Hospital, Fudan University, Shanghai, China. Hauptthemen laut MEDLINE: Transplantation, Heterologous, Skin Transplantation, Heterografts, Skin. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 199 Literaturangaben. Gefördert von: National Natural Science Foundation of China, National Key R&D Program of China, Major Science and Technology Project of Yunnan Province.
Abstract (Originalsprache)
Treatments of severe skin injuries have long been a clinical challenge. Early excision of necrotic tissue and skin grafting are essential, yet their effectiveness is hampered by several issues. Autologous and allogeneic skin shortages, the high cost of tissue‐engineered skin, and its failure to fully mimic natural skin architecture limit treatment options. Porcine skin is the ideal donor for skin xenotransplantation. It closely resembles human skin in anatomical structure and physiological function, has abundant availability, and involves fewer ethical concerns. Gene‐editing technologies allow for the genetic modification of pigs, minimizing xenogeneic immune rejection and zoonotic pathogen transmission risks, thus enhancing the scalability of porcine skin xenotransplantation. This article reviews advantages and limitations of porcine skin as a xenogeneic skin graft, along with the latest preclinical and clinical research on porcine skin xenotransplantation, with a particular emphasis on genetically modified pigs. It aims to highlight the significant potential of gene‐edited porcine skin xenotransplantation in treating severe skin wounds. Insights from skin xenotransplantation can also serve as a valuable reference for the development of other organ xenotransplantation. Trial Registration : ClinicalTrials.gov identifier: NCT03695939 and NCT06223269.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Dermatology, Huashan Hospital, Fudan University, Shanghai, China.
- Key Laboratory for Porcine Gene Editing and Xenotransplantation in Yunnan Province, Yunnan Agricultural University, Kunming, Yunnan, China.
- Xenotransplantation Research Engineering Center, Yunnan Agricultural University, Kunming, Yunnan, China.
- Department of Plastic Surgery, Xiangya Hospital, Central South University, Changsha, Hunan, China.
Förderung
- National Natural Science Foundation of China
- National Key R&D Program of China
- Major Science and Technology Project of Yunnan Province
- Ningwen Zhu in Yunnan Province
- National Key Research and Development Program of China
Zitieren
APA
Wu, D., Zhao, X. S., Zhao, H. F., Xie, J. H., Wei, H. J., & Zhu, N. W. (2025). New Hope for the Treatment of Severe Skin Injury: Genetically Engineered Porcine Skin Xenotransplantation. Xenotransplantation. https://doi.org/10.1111/xen.70057
Vancouver
Wu D, Zhao XS, Zhao HF, Xie JH, Wei HJ, Zhu NW. New Hope for the Treatment of Severe Skin Injury: Genetically Engineered Porcine Skin Xenotransplantation. Xenotransplantation. 2025. doi:10.1111/xen.70057
BibTeX
@article{Wu2025,
author = {Wu, Dan and Zhao, Xian-Sheng and Zhao, Hong-Fang and Xie, Jia-Heng and Wei, Hong-Jiang and Zhu, Ning-Wen},
title = {New Hope for the Treatment of Severe Skin Injury: Genetically Engineered Porcine Skin Xenotransplantation},
journal = {Xenotransplantation},
year = {2025},
doi = {10.1111/xen.70057}
}
EUVIMED